29 September 2022, Doha, Qatar – Sidra Medicine successfully concluded its Precision Medicine Functional Genomics symposium (PMFG 2022) to a packed audience of over 640 registered attendees during the course of the four-day event.
PMFG 2022 featured 50 international and local thought leaders and experts who discussed a range of hot topics including research and clinical advances in precision medicine; cancer immunotherapy and treatment; translational genomics and novel treatment programs related to rare and common diseases like diabetes and obesity.
Conference Chairs Dr. Chiara Cugno and Dr. Luis Saraiva said: “The feedback about PMFG 2022 from our peers within the research, healthcare and biomedical industries has been overwhelmingly positive. We want to thank everyone - from our speakers, attendees, sponsors, partners and exhibitors in making this year’s PMFG our best yet! Our conference was a true showcase of how precision medicine has moved from vision to practice. We are also proud of how Sidra Medicine has positioned itself within the precision medicine fraternity thanks to the mettle of our own researchers, clinicians and scientists and their contributions in drafting Qatar’s personalized health data ecosystem roadmap.